TABLE 2.
Disease model | Phytochemical | Dosage | Experimental model | Pathobiology | Alteration in molecular markers in response to treatment | References |
---|---|---|---|---|---|---|
DN | Berberine | 0.4 μM/L, 12 h | Podocytes cells treated with PA | Mitochondrial dysfunction, oxidative stress, apoptosis | ↓MMP-9, ↓Drp1, ↓MFF, ↓Fis1, ↓Mid49, ↓Mid51 | Qin et al. (2019) |
↓ROS, ↓MDA | ||||||
↑PGC-1α, ↑TFAM↑, ↑Nrf-1, ↑Nrf-2 | ||||||
↓caspase-3, ↓Bax, ↓cytochrome C | ||||||
↑Bcl-2 | ||||||
0.4 μM/L, 12 h | Podocytes cells treated with PA | Oxidative stress, mitochondrial dysfunction, lipid accumulation | ↓ROS, ↓MDA, ↑SOD | Qin et al. (2020) | ||
↑AMPK, ↑PGC-1α, ↑OXPHOS, ↑FAO | ||||||
↓FFA, ↓TG | ||||||
Polydatin | 25 mM, 24, 48, 72 h | HG-induced MPC5 cells | Apoptosis, mitochondrial fragmentation, dysfunction, oxidative stress | ↓Caspase 3, 9, ↓cytochrome-C | Ni et al. (2017) | |
↓Drp1 | ||||||
↓ROS | ||||||
Resveratrol | 10 μM, 6 h | Rat mesangial cells treated with high glucose | Oxidative stress, mitochondrial dysfunction | ↑MnSOD, ↓ROS | Xu et al. (2012) | |
↑mt complex III, ↑mtDNA | ||||||
↑ATP | ||||||
10 μM/L, 48 h | Podocytes exposed to high glucose | Oxidative stress, mitochondrial dysfunction | ↓mtROS | Zhang et al. (2019) | ||
↑mt respiratory chain complex I/III | ||||||
Obstructed nephropathy | Resveratrol | 5–20 μM, 72 h | HK-2 cells treated with TGF-β | Fibrosis | ↓FN, ↓α-SMA, ↓TGF-β1 | Liu et al. (2019) |
↓p-Smad3 | ||||||
Aged kidney | Resveratrol | 50µM, 24 h | H2O2-induced HK2 cells | Oxidative Stress | ↑HO-1, ↑NQO-1, ↑SOD1, ↑SOD2 | Kim et al. (2018) |
Sepsis-induced AKI | Curcumin | 0.3684 g, 12 d | LPS-induced HK-2 cells | Oxidative stress | ↓ROS | Wang et al. (2021a) |
Drug-induced AKI | Celastrol | 10–100 μM, 24 h | Cisplatin-induced HK-2 and RTECs | Mitochondrial dysfunction, inflammation, apoptosis | ↓KIM-1, ↑mtDNA, ↑MMP | Yu et al. (2018) |
↓IL-1β, ↓IL-6, ↓COX-2, ↓NF-κB, ↓ROS | ||||||
↑Bcl -2, ↓Bax, ↓Caspase-3 | ||||||
Chemical-induced AKI | Resveratrol | 50 μM/L, 30 min | Aldosterone induced podocytes | Mitochondrial dysfunction | ↑mtDNA, ↑PGC-1α, ↑TFAM, ↑SIRT3 | Yuan et al. (2012) |
Apoptosis | ↓caspase-9, ↓caspase-3 |
AMPK, AMP-activated protein kinase; BCL-2, B-cell lymphoma 2; Drp1, dynamin-related protein 1; FAO, fatty acid oxidation; FN, fibronectin; FFA, free fatty acids; Fis1, mitochondrial fission protein 1; HO-1, Heme oxygenase-1; HK-2, human renal proximal tubule epithelial cell line; HG, hyperglycemia; Mid51 and Mid49, mitochondrial dynamics proteins of 51 and 49 kDa; MMP, mitochondrial membrane potential; mtDNA, mitochondrial DNA; MFF, mitochondrial fission protein; MnSOD, manganese superoxide dismutase; MMP-9, matrix metalloproteinase-9; MDA, malondialdehyde; NQO-1, Quinone Oxidoreductase 1; Nrf-1 and Nrf-2, nuclear respiratory factors 1 and 2; OXPHOS, oxidative phosphorylation; PA, palmitic acid; PGC-1α, peroxisome proliferator-activated receptor-γ co-activator 1α; ROS, reactive oxygen species; SIRT3, silent mating type information regulation 2 homolog 3; SOD1 and SOD2, superoxide dismutase 1 and 2; TFAM, transcription factor A; TG, triglyceride.